|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| G01N 33/574 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| C12Q 1/68 | (2018.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K 35/17 | (2015.01) | ||
| A61K 35/15 | (2015.01) | ||
| G16B 30/00 | (2019.01) | ||
| G16B 40/00 | (2019.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Patento numeris | 3347039 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16763526.7 |
| Europos patento paraiškos padavimo data | 2016-09-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-07-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-08-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2016/071471 |
| Data | 2016-09-12 |
| (87) | Numeris | WO 2017/042394 |
| Data | 2017-03-16 |
| (30) | Numeris | Data | Šalis |
| 201516047 | 2015-09-10 | GB |
| (72) |
MCGRANAHAN, Nicholas , GB
ROSENTHAL, Rachel , GB
SWANTON, Charles , GB
PEGGS, Karl , GB
QUEZADA, Sergio , GB
|
| (73) |
Cancer Research Technology Limited ,
2 Redman Place, London E20 1JQ,
GB
|
| (54) | "IMMUNE CHECKPOINT INTERVENTION" IN CANCER |
| "IMMUNE CHECKPOINT INTERVENTION" IN CANCER |